OBJECTIVE: To evaluate the epidemiology of Giardia lamblia infection, investigate factors which might be associated with clinical manifestations and recurrence, and examine the role of copathogens in disease course. METHODS: Prospective 4-year cohort study of children born in an urban slum in north-eastern Brazil. RESULTS: Of 157 children followed for > or = 3 months, 43 (27.4%) were infected with Giardia. The organism was identified in 8.8% of all stool specimens, and although found with similar frequency in non-diarrhoeal (7.4%) and diarrhoeal stools (9.7%), was more common in children with persistent (20.6%) than acute diarrhoea (7.6%, P=0.002). Recurrent or relapsing infections were common (46%). Children with symptomatic infections had significantly lower weight-for-age and height-for-age than asymptomatic children. Copathogens were not associated with disease course. CONCLUSION With its protean clinical manifestations, Giardia may be associated with substantial morbidity amongst children in Brazil.
OBJECTIVE: To evaluate the epidemiology of Giardia lamblia infection, investigate factors which might be associated with clinical manifestations and recurrence, and examine the role of copathogens in disease course. METHODS: Prospective 4-year cohort study of children born in an urban slum in north-eastern Brazil. RESULTS: Of 157 children followed for > or = 3 months, 43 (27.4%) were infected with Giardia. The organism was identified in 8.8% of all stool specimens, and although found with similar frequency in non-diarrhoeal (7.4%) and diarrhoeal stools (9.7%), was more common in children with persistent (20.6%) than acute diarrhoea (7.6%, P=0.002). Recurrent or relapsing infections were common (46%). Children with symptomatic infections had significantly lower weight-for-age and height-for-age than asymptomatic children. Copathogens were not associated with disease course. CONCLUSION With its protean clinical manifestations, Giardia may be associated with substantial morbidity amongst children in Brazil.
Authors: N Sawangjaroen; S Subhadhirasakul; S Phongpaichit; C Siripanth; K Jamjaroen; K Sawangjaroen Journal: Parasitol Res Date: 2004-11-18 Impact factor: 2.289
Authors: Jeffrey W Priest; Delynn M Moss; Govinda S Visvesvara; Cara C Jones; Anna Li; Judith L Isaac-Renton Journal: Clin Vaccine Immunol Date: 2010-09-28
Authors: Sitara S R Ajjampur; Premi Sankaran; Arun Kannan; Kirthi Sathyakumar; Rajiv Sarkar; Beryl P Gladstone; Gagandeep Kang Journal: Am J Trop Med Hyg Date: 2009-01 Impact factor: 2.345
Authors: Maria-Graciela Hollm-Delgado; Robert H Gilman; Caryn Bern; Lilia Cabrera; Charles R Sterling; Robert E Black; William Checkley Journal: Am J Epidemiol Date: 2008-07-31 Impact factor: 4.897
Authors: Marta Cecilia Minvielle; Betina Cecilia Pezzani; María Alejandra Cordoba; María Marta De Luca; María Carmen Apezteguia; Juan Angel Basualdo Journal: Korean J Parasitol Date: 2004-09 Impact factor: 1.341
Authors: Anita Kohli; Oluma Y Bushen; Relana C Pinkerton; Eric Houpt; Robert D Newman; Cynthia L Sears; Aldo A M Lima; Richard L Guerrant Journal: Trans R Soc Trop Med Hyg Date: 2008-05-16 Impact factor: 2.184
Authors: Luther A Bartelt; James Roche; Glynis Kolling; David Bolick; Francisco Noronha; Caitlin Naylor; Paul Hoffman; Cirle Warren; Steven Singer; Richard Guerrant Journal: J Clin Invest Date: 2013-06 Impact factor: 14.808